Beta-amyloid peptide binding protein does not couple to G protein in a heterologous Xenopus expression system

J Neurosci Res. 2003 Jul 15;73(2):255-9. doi: 10.1002/jnr.10652.

Abstract

Alzheimer's disease is a neurodegenerative disorder related to the formation of protein aggregates. beta-Amyloid protein (A beta), generated by enzymatic cleavage of amyloid precursor protein (APP), can cause such aggregation, and these aggregates may cause neuronal cell death by inducing apoptosis. However, A beta-induced intracellular signaling pathways involved in the neuronal death are not well understood. Recently it was shown that A beta aggregates induce neuronal cell death via beta-amyloid peptide-binding protein (BBP), a receptor for A beta in BBP-transfected cells, which is known to be sensitive to pertussis toxin, a G alpha(i/o) family inhibitor. However, the actual coupling of BBP to the pertussis-sensitive G protein was not demonstrated. In this study, we performed electrophysiological recordings using the two-electrode voltage-clamp technique to test whether human or Drosophila BBPs, singly or in combination with APP, are coupled to a specific type of G protein. Our results suggest that BBP is not directly coupled to G alpha(i/o), G alpha(s), or G alpha(q) proteins and that BBP may need a component other than APP to exert its toxic effect in concert with A beta.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Carrier Proteins / metabolism*
  • Drosophila / genetics
  • Drosophila / metabolism
  • Female
  • GTP-Binding Proteins / metabolism*
  • Gene Expression Regulation / physiology*
  • Humans
  • Membrane Proteins
  • Oocytes / metabolism
  • PC12 Cells
  • Patch-Clamp Techniques
  • Rats
  • Transfection
  • Xenopus / genetics
  • Xenopus / metabolism*

Substances

  • Amyloid beta-Peptides
  • Carrier Proteins
  • Membrane Proteins
  • TM2D1 protein, human
  • GTP-Binding Proteins